The senior management consists of the Chief Executive Officer, the Chief Financial Officer and one Partner.
Ted Fjällman
Member of the Management team
Ted Fjällman
Born 1978. CEO since 2024 (2023).
—
Education: PhD in Biotechnology and Immunology from The University of Guelph, MSS from ISU, France, MSc from Gothenburg University, BSc from University of Waikato, New Zeeland.
Other relevant experience: More than 25 years of experience from various R&D roles, CEO of Prokarium Ltd.
Other ongoing assignments: Director of Roseberry AG, Tekiu Ltd and St Andrews Folkestone Ltd.
Previous assignments completed within the past five years: –
Holdings* in the Company: 94,985,934 shares.
*Includes holdings by self and controlled companies
Cecilia Schéele
Member of the Management team
Cecilia Schéele
Born 1972. CFO since 2024 (2021). Deputy CEO since 2024 (2023).
—
Education: MSc International Business Administration from Lund University.
Other relevant experience: More than 20 years of experience in finance from various positions at Recipharm, KPMG, and working with the IPO of Viva Wine Group.
Other ongoing assignments: Board member of Stockholm Cairn and deputy board member of Binno AB.
Previous assignments completed within the past five years: Board member of Binno AB, deputy board member of RPH Iberia AB and Recipharm Strängnäs Fastighets AB.
Holdings in the Company: 4,046,462 shares.
Mark Quick
Member of the Management team
Mark Quick
Born 1966. Partner since 2024 (2022).
—
Education: BSc Hons Industrial Studies from Nottingham Trent university, MBA from The Open University Business School.
Other relevant experience: More than 35 years of experience in business development and mergers and acquisitions from various positions at Recipharm, Celltech and Medeva.
Other ongoing assignments: –
Previous assignments completed within the past five years: Board member of various Recipharm AB subsidiaries.
Holdings in the Company: 40,654,121 shares.